Category: MassDevice.com Earnings Roundup
A voluntary recall initiated yesterday pushes HeartWare shares down today, despite 2nd-quarter result that crushed expectations on Wall Street.
UPDATED July 31, 2014 with additional comment on recall.
Teleflex gets some Wall Street love after reporting double-digit revenue growth in Q2, beating analysts' expectations and raising its adjusted per-share earnings guidance for the rest of the year.
Wayne, Pa.-based Teleflex (NYSE:TFX) served up some good news today with strong numbers for its 2nd quarter and an increased outlook on the year.
The company posted an 11.4% increase in sales and an 11.3% increase in profits, with adjusted earnings coming in almost 19% higher year-over-year.
Abiomed said today that it expects the FDA to grant the pre-market approval application for its flagship Impella heart pump sooner rather than later, pushing up the timeline to March 2015.
Haemonetics shares gain slightly after the blood management company beats expectations for its fiscal 1st-quarter sales and earnings.
Haemonetics (NYSE:HAE) shares ticked up today after the blood management company beat expectations with its fiscal 1st-quarter results.
NuVasive shares surge more than 10% as the medical device company raises its outlook for the rest of the year after posting 2nd-quarter sales and earnings numbers that beat estimates.
Edwards Lifesciences boosts its full-year guidance as sales surge in Q2, and the company pads its bottom line with a $750 million settlement from Medtronic.
Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.
Sluggish healthcare sales drag down Philips overall figures, but the company is eying a comeback for the 2nd half of the year.
Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.